Eton Pharmaceuticals (ETON) Receivables: 2019-2025
Historic Receivables for Eton Pharmaceuticals (ETON) over the last 5 years, with Sep 2025 value amounting to $13.1 million.
- Eton Pharmaceuticals' Receivables rose 133.98% to $13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.2 million, marking a year-over-year increase of 105.48%. This contributed to the annual value of $5.4 million for FY2024, which is 57.17% up from last year.
- Eton Pharmaceuticals' Receivables amounted to $13.1 million in Q3 2025, which was down 9.49% from $14.5 million recorded in Q2 2025.
- Over the past 5 years, Eton Pharmaceuticals' Receivables peaked at $14.5 million during Q2 2025, and registered a low of $300,000 during Q1 2021.
- Its 3-year average for Receivables is $5.9 million, with a median of $4.3 million in 2025.
- Its Receivables has fluctuated over the past 5 years, first spiked by 10,316.67% in 2021, then plummeted by 62.96% in 2022.
- Quarterly analysis of 5 years shows Eton Pharmaceuticals' Receivables stood at $5.0 million in 2021, then tumbled by 62.96% to $1.9 million in 2022, then soared by 84.18% to $3.4 million in 2023, then spiked by 57.17% to $5.4 million in 2024, then surged by 133.98% to $13.1 million in 2025.
- Its last three reported values are $13.1 million in Q3 2025, $14.5 million for Q2 2025, and $4.3 million during Q1 2025.